Arcturus Therapeutics Holdings Inc (ARCT)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2024-10-16 | 2024-10-15 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
12 000
-2.7%
20,76249 121 USD |
12 000 -2.7% | 20,76 | 249 121 USD | |
| 2024-06-14 | 2024-06-12 | V Vente |
Chief Financial Officer Administrateur exécutif |
50 000
-18.5%
32,031 601 500 USD |
50 000 -18.5% | 32,03 | 1 601 500 USD | |
| 2024-06-07 | 2024-06-05 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
114
-0.0%
45,005 130 USD |
114 -0.0% | 45,00 | 5 130 USD | |
| 2024-06-04 | 2024-06-03 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
26 000
-5.5%
40,011 040 234 USD |
26 000 -5.5% | 40,01 | 1 040 234 USD | |
| 2024-03-27 | 2024-03-25 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
17 435
-3.6%
35,02610 574 USD |
17 435 -3.6% | 35,02 | 610 574 USD | |
| 2024-03-21 | 2024-03-19 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
8 565
-1.7%
35,01299 839 USD |
8 565 -1.7% | 35,01 | 299 839 USD | |
| 2023-11-03 | 2023-11-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-1.0%
18,7293 602 USD |
5 000 -1.0% | 18,72 | 93 602 USD | |
| 2023-10-04 | 2023-10-02 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-1.0%
25,61128 062 USD |
5 000 -1.0% | 25,61 | 128 062 USD | |
| 2023-09-05 | 2023-09-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-1.0%
31,45157 264 USD |
5 000 -1.0% | 31,45 | 157 264 USD | |
| 2023-08-03 | 2023-08-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-1.0%
34,91174 550 USD |
5 000 -1.0% | 34,91 | 174 550 USD | |
| 2023-07-18 | 2023-07-14 | VP Vente planifiée |
See Remarks Dirigeant |
6 968
-88.0%
35,00243 880 USD |
6 968 -88.0% | 35,00 | 243 880 USD | |
| 2023-07-18 | 2023-07-14 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
25 000
-4.6%
35,01875 250 USD |
25 000 -4.6% | 35,01 | 875 250 USD | |
| 2023-07-07 | 2023-07-03 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-0.9%
28,75143 750 USD |
5 000 -0.9% | 28,75 | 143 750 USD | |
| 2023-06-05 | 2023-06-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-0.9%
27,16135 800 USD |
5 000 -0.9% | 27,16 | 135 800 USD | |
| 2023-05-12 | 2023-05-11 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
7 925
-1.4%
30,24239 652 USD |
7 925 -1.4% | 30,24 | 239 652 USD | |
| 2023-05-12 | 2023-05-10 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
17 075
-2.9%
30,00512 250 USD |
17 075 -2.9% | 30,00 | 512 250 USD | |
| 2023-05-03 | 2023-05-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-0.9%
25,93129 650 USD |
5 000 -0.9% | 25,93 | 129 650 USD | |
| 2023-04-19 | 2023-04-18 | VP Vente planifiée |
See Remarks Dirigeant |
6 968
-88.0%
28,18196 358 USD |
6 968 -88.0% | 28,18 | 196 358 USD | |
| 2023-04-05 | 2023-04-03 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-0.8%
25,38126 900 USD |
5 000 -0.8% | 25,38 | 126 900 USD | |
| 2023-03-08 | 2023-03-06 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
5 000
-0.8%
16,0780 350 USD |
5 000 -0.8% | 16,07 | 80 350 USD | |
| 2022-12-19 | 2022-12-15 | A Achat | Administrateur non-exécutif |
2 222
+9.8%
18,0039 996 USD |
2 222 +9.8% | 18,00 | 39 996 USD | |
| 2022-11-28 | 2022-11-23 | A Achat |
President and CEO Administrateur exécutif |
5 000
+0.3%
16,5182 550 USD |
5 000 +0.3% | 16,51 | 82 550 USD | |
| 2022-01-06 | 2022-01-04 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
8 100
-1.3%
40,00324 000 USD |
8 100 -1.3% | 40,00 | 324 000 USD | |
| 2021-12-20 | 2021-12-16 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
3 633
-0.6%
40,00145 328 USD |
3 633 -0.6% | 40,00 | 145 328 USD | |
| 2021-12-10 | 2021-12-08 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
6 367
-1.0%
40,00254 680 USD |
6 367 -1.0% | 40,00 | 254 680 USD | |
| 2021-11-03 | 2021-11-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.6%
44,41444 100 USD |
10 000 -1.6% | 44,41 | 444 100 USD | |
| 2021-10-04 | 2021-10-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.6%
44,36443 600 USD |
10 000 -1.6% | 44,36 | 443 600 USD | |
| 2021-04-05 | 2021-04-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.5%
42,95429 500 USD |
10 000 -1.5% | 42,95 | 429 500 USD | |
| 2021-03-03 | 2021-03-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.5%
54,23542 300 USD |
10 000 -1.5% | 54,23 | 542 300 USD | |
| 2021-02-03 | 2021-02-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.5%
75,31753 100 USD |
10 000 -1.5% | 75,31 | 753 100 USD | |
| 2021-01-05 | 2021-01-04 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.4%
46,40464 000 USD |
10 000 -1.4% | 46,40 | 464 000 USD | |
| 2020-12-10 | 2020-12-09 | V Vente |
Ultragenyx Pharmaceutical Inc. Administrateur non-exécutif Actionnaire important |
357 745
-14.0%
94,9733 975 043 USD |
357 745 -14.0% | 94,97 | 33 975 043 USD | |
| 2020-12-10 | 2020-12-08 | V Vente |
Ultragenyx Pharmaceutical Inc. Administrateur non-exécutif Actionnaire important |
442 255
-14.7%
105,5446 675 593 USD |
442 255 -14.7% | 105,54 | 46 675 593 USD | |
| 2020-12-03 | 2020-12-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.4%
96,19961 900 USD |
10 000 -1.4% | 96,19 | 961 900 USD | |
| 2020-11-03 | 2020-11-02 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.4%
55,28552 800 USD |
10 000 -1.4% | 55,28 | 552 800 USD | |
| 2020-10-02 | 2020-10-01 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.4%
42,83428 300 USD |
10 000 -1.4% | 42,83 | 428 300 USD | |
| 2020-09-04 | 2020-09-03 | VP Vente planifiée |
Chief Scientific Officer & COO Dirigeant |
10 000
-1.4%
45,16451 600 USD |
10 000 -1.4% | 45,16 | 451 600 USD | |
| 2020-06-12 | 2020-06-12 | A Achat |
See Remarks Dirigeant |
450
+90.0%
33,3314 999 USD |
450 +90.0% | 33,33 | 14 999 USD | |
| 2020-06-10 | 2020-06-10 | A Achat |
President and CEO Administrateur exécutif |
1 000
+0.1%
31,6931 690 USD |
1 000 +0.1% | 31,69 | 31 690 USD | |
| 2020-06-10 | 2020-06-10 | A Achat |
Chief Financial Officer Administrateur exécutif |
5 000
+1.9%
29,74148 700 USD |
5 000 +1.9% | 29,74 | 148 700 USD | |
| 2019-12-09 | 2019-12-05 | A Achat |
SASSINE ANDY Chief Financial Officer Administrateur exécutif |
5 649
+2.2%
9,7354 965 USD |
5 649 +2.2% | 9,73 | 54 965 USD | |
| 2019-12-05 | 2019-12-03 | A Achat |
SASSINE ANDY Chief Financial Officer Administrateur exécutif |
10 000
+4.0%
10,00100 000 USD |
10 000 +4.0% | 10,00 | 100 000 USD | |
| 2019-09-17 | 2019-09-13 | A Achat |
2 300
+11.3%
10,5824 334 USD |
2 300 +11.3% | 10,58 | 24 334 USD | ||
| 2019-09-12 | 2019-09-12 | A Achat |
See Remarks |
500
+inf%
10,695 347 USD |
500 +inf% | 10,69 | 5 347 USD | |
| 2019-08-30 | 2019-08-29 | A Achat |
Payne Joseph E President and CEO Administrateur exécutif Actionnaire important |
5 000
+0.3%
11,2256 100 USD |
5 000 +0.3% | 11,22 | 56 100 USD | |
| 2019-08-26 | 2019-08-23 | A Achat |
SASSINE ANDY Chief Financial Officer Dirigeant |
10 000
+4.2%
10,90109 000 USD |
10 000 +4.2% | 10,90 | 109 000 USD | |
| 2019-08-21 | 2019-08-20 | A Achat |
FARRELL PETER C Administrateur non-exécutif |
4 432
+11.5%
10,8548 087 USD |
4 432 +11.5% | 10,85 | 48 087 USD | |
| 2019-08-21 | 2019-08-19 | A Achat |
FARRELL PETER C Administrateur non-exécutif |
4 681
+13.8%
11,0251 585 USD |
4 681 +13.8% | 11,02 | 51 585 USD |